Gonarthrosis: prevalence and differential approach to endoprosthesis

December 16, 2021

Gonarthrosis is one of the most actual and complex problems of modern orthopedics, affecting more than 250 million people worldwide, is the leading cause of severe pain in the elderly, leads to disability and is associated with an increased risk of death. At the present stage, total knee arthroplasty is the most effective and generally accepted method of treating gonarthrosis at the final stage of the disease. There are no other effective treatment for patients with osteoarthritis of the knee at this stage of the disease. The article considers the peculiarities of surgical treatment, the choice of endoprosthesis and presents our own experience of successful total knee arthroplasty in patients with gonarthrosis.


  • 1. Vina E.R., Kwoh C.K. (2018) Epidemiology of osteoarthritis: literature update. Curr. Opin. Rheumatol., 30(2): 160–167. doi: 10.1097/BOR.0000000000000479.
  • 2. Palazzo C., Ravaud J.F., Papelard A. et al. (2014) The burden of musculoskeletal conditions. PLoS One, 9(3): e90633. doi:10.1371/journal.pone.0090633.
  • 3. Nuesch E., Dieppe P., Reichenbach S. et al. (2011) All cause and disease specific mortality in patients with knee or hip osteoarthritis: population based cohort study. BMJ, 342: 1165.
  • 4. Breivik H., Collett B., Ventafridda V. et al. (2006) Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur. J. Pain, 10(4): 287–333. doi: 10.1016/j.ejpain.2005.06.009.
  • 5. Golovach I.Yu. (2014) Osteoarthritis: modern fundamental and applied aspects of the pathogenesis of the disease. Pain Joints Spine, 3(15).
  • 6. Berenbaum F., Griffin T.M., Liu-Bryan R. (2017) Metabolic Regulation of Inflammation in Osteoarthritis. Arthritis Rheum., 69(1): 9–21.
  • 7. Felson D.T. (2013) Osteoarthritis as a disease of mechanics. Osteoarthritis Cartilage, 21: 10–15. doi: 10.1016/j.joca.2012.09.012.
  • 8. Corvol M.T., Malemud C.J., Sokoloff L. (1972) A pituitary growth promoting factor for articular chondrocytes in monolayer culture. Endocrinology, 90(1): 262–271. doi: 10.1210/endo-90-1-262.
  • 9. Pelletier J.P., Roughley P.J., DiBattista J.A. et al. (1991) Are cytokines involved in osteoarthritic pathophysiology? Semin. Arthritis Rheum., 20(6 Suppl. 2): 12–25. doi:10.1016/0049-0172(91)90024-t.
  • 10. Goldring M.B., Otero M. (2011) Inflammation in osteoarthritis. Curr. Opin. Rheumatol., 23(5): 471–478. doi: 10.1097/BOR.0b013e328349c2b1
  • 11. Ayral X., Pickering E.H., Woodworth T.G. et al. (2005) Synovitis: a potential predictive factor of structural progression of medial tibiofemoral knee osteoarthritis: results of a 1 year longitudinal arthroscopic study in 422 patients. Osteoarthritis Cartilage, 13: 361–367.
  • 12. Loeser R.F., Goldrina S.R., Scanzello C.R. et al. (2012) Osteoarthritis: A Disease of the Joint as an Organ. Arthritis Rheum., 64(6): 1697–1707.
  • 13. Kim J.R., Yoo J.J., Kim H.A. (2018) Therapeutics in Osteoarthritis Based on an Understanding of Its Molecular Pathogenesis. Int. J Mol. Sci., 19(3): 674. doi:10.3390/ijms19030674.
  • 14. Guilak F. (2011) Biomechanical factors in osteoarthritis. Best Pract. Res. Clin. Rheumatol., 25(6): 815–823. doi: 10.1016/j.berh.2011.11.013
  • 15. Stevens A.L., Wishnok J.S., White F.M. et al. (2009) Mechanical injury and cytokines cause loss of cartilage integrity and upregulate proteins associated with catabolism, immunity, inflammation, and repair. Mol. Cell Proteomics, 8(7): 1475–1489.
  • 16. Sharma V., Anuvat K., John L. et al. (2017) Scientific American Pain Management — Arthritis of the knee. Decker: Pain related disease states.
  • 17. Тихилов Р.М., Корнилов Н.Н., Куляба Т.А. и др. (2014) Сравнительный анализ регистров эндопротезирования коленного сустава (обзор л-ры). Травматол. и ортопедия России, 2: 112–121.
  • 18. Bruyèreab O., Honvoab G., Veronesec N. et al. (2019) An updated algorithm recommendation for the management of knee osteoarthritis from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Semin. Arthritis Rheum., 49(3): 337–350. doi: 10.1016/j.semarthrit.2019.04.008.
  • 19. Shil’nikov V.A., Tikhilov R.M., Denisov A.O. (2008) Pain after total hip arthroplasty. Traumatology and Orthopedics of Russia, 2: 106–109.
  • 20. Lee K., Goodman S.B. (2008) Current state and future of joint replacements in the hip and knee. Expert Rev. Med. Devices, 5(3): 383–393. doi: 10.1586/17434440.5.3.383.
  • 21. Kurtz S. (2005) Prevalence of primary and revision total hip and knee arthroplasty in the United States from 1990 through 2002. JBJS Am., 87(7): 1487–1497.
  • 22. Kulyaba T.A., Kornilov N.N., Tikhilov R.M. et al. (2008) Knee arthroplasty using articulated implants. Traumatology and Orthopedics of Russia, 2(48): 110–114.
  • 23. Goodfellow J., O’Connor J. (1978) The mechanics of the knee and prosthesis design. Bone Joint Surg., 60(3): 358–369.
  • 24. Heck D.A., Melfi C.A., Mamlin L.A. et al. (1998) Revision rates after knee replacement in the United. Med. Care., 36: 661–669.
  • 25. Moreland J.R. (1988) Mechanisms of failure in total knee arthroplasty. Clin. Orthop.: 49–64.
  • 26. Namba R., Graves S., Robertsson O. et al. (2014) International comparative evaluation of knee replacement with fixed or mobile non-posterior-stabilized implants. J. Bone Joint Surg. Am., 96 (Suppl. 1.): 52–58.
  • 27. Vaidya C., Alvarez E., Vinciguerra J. et al. (2011) Reduction of total knee replacement wear with vitamin E blended highly cross-linked ultra-high molecular weight polyethylene. Proc. Inst. Mech. Eng. H., 225(1): 1–7.
  • 28. Essner A., Herrera L., Hughes P. et al. (2011) The influence of material and design on total knee replacement. J. Knee Surg., 24(1): 9–17.
  • 29. Huj C., Salmon L., Maeno S. et al. (2011) Five-year comparison of oxidized zirconium and cobalt-chromium femoral components in total knee arthroplasty: a randomized controlled trial. J. Bone Join Surg. Am., 93(7): 624–630.
  • 30. Veigl D., Vavřík P., Pokorný D. et al. (2011) Comparison of in vivo characteristics of polyethylene wear particles produced by a metal and a ceramic femoral component in total knee replacement. Acta Chir. Orthop. Traumatol. Cech., 78(1): 49–55.
  • 31. Browne J.A., Gall Sims S.E., Giuseffi S.A. et al. (2011) All-polyethylene tibial components in modern total knee arthroplasty. J. Am. Acad. Orthop. Surg., 19(9): 527–535.
  • 32. Willing R., Kim I.Y. (2011) Design optimization of a total knee replacement for improved constraint and flexion kinematics. J. Biomech., 44(6): 1014–1020.
  • 33. Guy S.P., Farndon M.A., Sidhom S. et al. (2012) Gender differences in distal femoral morphology and the role of gender specific implants in total knee replacement: A prospective clinical study. Knee, 19(1): 28–31.
  • 34. Gaiko G.V., Zayets V.B., Kalashnikov O.V. et al. (2017) Hirurgical treatment of ailments to gonarthrosis (literature review, I part). Bulletin of Orthopedics, Traumatology and Prosthetics, 1: 56–60.
  • 35. Gaiko G.V., Osadchuk T.I., Zayets V.B. et al. (2017) Differential approach to knee arthroplasty in patients with gonarthrosis depending on the severity of the lesion. Bulletin of Orthopedics, Traumatology and Prosthetics, 2: 59–66.
  • 36. Kalashnikov A.V., Osadchuk T.I. (2019) Our approach to knee arthroplasty in patients with gonarthrosis. Problems of traumatology and osteosynthesis, 1–2 (15–16).